Tag: Covid Vaccine

covaxin
Covid Vaccine Alert: Phase III Trials Of Covaxin In Odisha Soon

Bhubaneswar: The third and final phase of the ongoing clinical trials of Covaxin – India’s indigenous Covid-19 vaccine candidate will shortly begin in Odisha. The Phase III trials of Covaxin will be conducted at 21 centres across India and at SUM hospital in Odisha (Bhubaneswar). The vaccine will be administered to nearly 2,000 volunteers in […]

  • Saturday, 10 April 2021
Vaccine
Israel To Start Human Trials Of COVID Vaccine On Nov 1

Jerusalem: Israel Institute for Biological Research (IIBR) will start human clinical trials of its COVID-19 vaccine candidate Brilife from November 1 after receiving all necessary approvals from the Ministry of Health and the Helsinki Committee, the Israeli Defence Ministry said. The Helsinki Committee deals with research approval and human experiments. The committee is mandated to […]

  • Saturday, 10 April 2021
Sputnik V
COVID Vaccine: Russia Seeks Sputnik V's Speedy Registration, Prequalification From WHO

New Delhi: The Russian Direct Investment Fund, the country’s sovereign wealth fund, has submitted applications to the World Health Organisation (WHO) for accelerated registration and prequalification of Sputnik V, the world’s first registered vaccine against the coronavirus. Russia has become one of the first countries to apply to WHO for prequalification of its vaccine against […]

  • Saturday, 10 April 2021
Centre Asks States To Form Committees To Ensure Smooth COVID-19 Vaccination Drive
Centre Asks States To Form Committees To Ensure Smooth COVID-19 Vaccination Drive

New Delhi: The Centre has asked states to constitute committees for coordination and overseeing COVID-19 vaccination drive while ensuring minimal disruptions in other routine healthcare services, and stressed early tracking of social media to dispel rumours which could impact the community acceptance of coronavirus inoculation. Stating that COVID-19 vaccine introduction will span over a year […]

  • Saturday, 10 April 2021
BCG Vaccine May Help Elderly Fight Against Covid-19: ICMR
BCG Vaccine May Help Elderly Fight Against Covid-19: ICMR

New Delhi: The Bacille Calmette-Guerin or BCG vaccine, originally made against tuberculosis, may help in the management of Covid-19, especially in the elderly, says a study by the Indian Council of Medical Research (ICMR). The BCG vaccination is known to induce innate immune memory, which confers protection against several infections, the study uploaded as preprint […]

  • Saturday, 10 April 2021
Rajesh-Bhusan
COVID-19 Vaccine Distribution In India To Take One Year, Healthcare Workers To Get First

New Delhi: The government has planned to start the distribution of Covid-19 vaccine first to the healthcare workers followed by other groups to be added “sequentially”. The distribution drive would take place over a year. For this, the states and union territories would form a three-tier system as per the Centre’s directions. “In all likelihood, […]

  • Saturday, 10 April 2021
CureVac Covid Vaccine Induces Immune Response In Early Trial
CureVac Covid Vaccine Induces Immune Response In Early Trial

Berlin: German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and triggered immune response among volunteers. The vaccine candidate was generally well tolerated across all tested doses and induced strong binding and neutralising antibody responses in addition to first indication of […]

  • Saturday, 10 April 2021
COVID19-Vaccinations
Nanoparticle Vaccine Candidate For Covid Produces Antibodies: Study

Washington: An innovative nanoparticle vaccine candidate for the Covid-19 virus produces virus-neutralizing antibodies in mice at levels 10X greater than is seen in people who have recovered from the infections, say researchers. Designed by scientists at the University of Washington School of Medicine in Seattle, the vaccine candidate has been transferred to two companies for […]

  • Saturday, 10 April 2021
Sputnik V
Sputnik V Vaccine 92 Per Cent 'Effective' Against Coronavirus, Claims Russia

Moscow: Russia’s Sputnik V vaccine has shown 92 per cent efficacy in preventing COVID-19, according to interim trial results announced by the country’s health ministry on Wednesday. The announcement follows results unveiled earlier this week by vaccine developers Pfizer and BioNTech, who said their vaccine was more than 90 per cent effective at preventing COVID-19. […]

  • Friday, 09 April 2021
COVID-19-Vaccine
India Needs 1.7 Billion Covid Vaccine Doses For Adult Population

New Delhi: The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&J and the earliest efficacy data is expected by the end of November-December 2020 and in the best case, vaccines can be rolled out in January 2021. According to a research by Credit Suisse, India needs about 1.7 billion Covid-19 vaccine […]

  • Friday, 09 April 2021
Herd Immunity May Come Before Covid Vaccine Goes Off The Shelf: AIIMS Director
Herd Immunity May Come Before Covid Vaccine Goes Off The Shelf: AIIMS Director

New Delhi: AIIMS Director Dr Randeep Guleria informed, we may reach a stage down the line where we may have a good amount of immunity, and the people may feel that there is now good immunity and the utility of the vaccine is not there. If the virus doesn’t mutate or does not cause changes […]

  • Friday, 09 April 2021
Indian Health Experts Hail mRNA Vaccine For Covid Treatment
Indian Health Experts Hail mRNA Vaccine For Covid Treatment

New Delhi: With the two mRNA vaccine candidates from pharma giants Pfizer-BioNTech and Moderna showing effectiveness in preventing Covid-19 in an interim analysis, health experts in India on Tuesday said that mRNA vaccine that works on previously unproven technology can be very promising in the fight against the pandemic despite the challenges. To date, no […]

  • Friday, 09 April 2021
Naba Das
Odisha Prepared For Covid Vaccination Drive As Per Centre’s Guidelines, Says Health Minister

Bhubaneswar: While the Serum Institute of India is optimistic about making the Oxford Covid-19 vaccine available for healthcare workers, elderly people by around February 2021 and by April for general public, Odisha Health and Family Welfare Minister, Naba Kishore Das on Friday stated that the State government is ready for a mass vaccination drive to […]

  • Friday, 09 April 2021
PM Modi Reviews Preparedness Of COVID19 Vaccine Delivery

New Delhi: Prime Minister Narendra Modi, today reviewed the preparedness of Covid-19 vaccine delivery, distribution and administration. Prime Minister appreciated the efforts of innovators, scientists, academicians and pharma-companies in their efforts to develop vaccines and has directed that every effort should be made to facilitate the research, development and manufacturing of the vaccine. Five vaccines […]

  • Friday, 09 April 2021
Oxford AstraZeneca Vaccine 70% Effective In Preventing COVID19
All Eyes Now On Covid-19 Vaccine Availability

New Delhi/Bhubaneswar: Of all the Covid vaccine candidates, who will be the first to achieve a near-complete efficacy is what everyone awaits now. On Monday, the university of Oxford achieved a significant milestone in the fight against Covid. Interim data shows the Oxford vaccine is 70.4 per cent effective, while tests on two dose regimens […]

  • Friday, 09 April 2021
scrollToTop